MCQ
Health, Food & Nutrition MCQ - Practice Questions with Answers
Solve 219 Health, Food & Nutrition questions for RAS/RPSC preparation.
Practice questions
Q1On March 21, 2026, multiple Indian pharmaceutical companies launched generic versions of semaglutide. Which of the following statements about semaglutide is/are CORRECT? 1. Semaglutide is a GLP-1 receptor agonist used for Type 2 diabetes and obesity. 2. Novo Nordisk's core Indian patent for semaglutide expired on March 21, 2026. 3. NATCO Pharma was the only company to launch a generic version on Day 1. Select the correct answer using the code below:
Statements 1 and 2 are correct. Semaglutide is indeed a GLP-1 receptor agonist approved for Type 2 diabetes (Ozempic®) and obesity (Wegovy®). Novo Nordisk's core Indian patent expired on March 21, 2026, triggering simultaneous generic launches. Statement 3 is INCORRECT — multiple companies launched generics on Day 1, including Dr. Reddy's (Obeda™), Zydus (Semaglyn™/Mashema™/Alterme™), Alkem (Semasize™/Obesema™/Hepaglide™), NATCO Pharma, Sun Pharma, and Glenmark. NATCO was among the first to announce pricing at ₹1,290/month but was not the only company.
Q2Onchocerciasis is transmitted through the bites of which insect?
Onchocerciasis is transmitted through bites of infected Simulium blackflies that breed near fast-flowing rivers.
Q3Consider the following statements: 1. Dengue virus is transmitted to humans through the bites of infected female mosquitoes. 2. Aedes aegypti is the primary mosquito vector of dengue. 3. Dengue is primarily transmitted by female Anopheles mosquitoes. Which of the statements given above are correct?
Statements 1 and 2 are correct according to WHO. Statement 3 is incorrect because Anopheles mosquitoes are associated with malaria transmission, whereas dengue is primarily transmitted by Aedes aegypti.
Q4Consider the following statements: 1. Ayushman Bharat Digital Mission creates a 14-digit ABHA number as a unique health identity. 2. eSanjeevani supports both doctor-to-doctor and patient-to-doctor teleconsultations. 3. CoWIN was developed for malaria vaccination registration and certificates. 4. PM-JAY provides a health cover of Rs. 5 lakh per family per year for eligible families. Which of the statements given above are correct?
Statements 1, 2 and 4 are correct. ABDM uses a 14-digit ABHA number, eSanjeevani provides both provider-to-provider and patient-to-provider telemedicine services, and PM-JAY gives Rs. 5 lakh cover per family per year. Statement 3 is incorrect because CoWIN was for COVID-19 vaccination, not malaria vaccination.
Q5Consider the following statements about nutrition programmes and indicators under NHM: 1. NFHS-5 recorded stunting among children under 5 years at 35.5%. 2. NFHS-5 recorded wasting among children under 5 years at 32.1%. 3. Anaemia Mukt Bharat uses a 6X6X6 strategy covering six beneficiary age groups and six interventions. 4. Vitamin-A supplementation under NHM covers children aged 9-59 months biannually. Which of the statements given above are correct?
Statements 1, 3 and 4 are correct. NHM's nutrition page records stunting at 35.5%, describes the 6X6X6 AMB strategy, and gives Vitamin-A supplementation for 9-59 months biannually. Statement 2 is incorrect because wasting is listed as 19.3%, while 32.1% is underweight.
You've seen 5 of 219 sample questions
Unlimited practice on Health, Food & Nutrition comes with the RAS Test Series + Practice pack or Gate Pass.
More questions
6What is the case fatality rate of Nipah virus?
7The Biological E's Corbevax COVID-19 vaccine uses which platform?
8Consider the following statements: 1. Covaxin was developed by Bharat Biotech in collaboration with ICMR and NIV, Pune, and is an inactivated whole-virion vaccine. 2. Covishield was developed by Oxford-AstraZeneca and manufactured by Serum Institute of India. 3. iNCOVACC is India's intranasal COVID vaccine. 4. ZyCoV-D was the world's first mRNA-based COVID-19 vaccine approved in India. Which of the statements given above are correct?
9Consider the following statements: 1. India's Universal Immunization Programme covers 12 vaccine-preventable diseases. 2. Mission Indradhanush was launched in December 2014. 3. In 2021, IDSP shifted to near-real-time reporting through IHIP. 4. National Health Mission was launched in 2005 by subsuming NRHM and NUHM. Which of the statements given above are correct?
10Consider the following statements: 1. India's Universal Immunization Programme covers 12 vaccine-preventable diseases. 2. Chandipura virus is primarily transmitted through sandfly bites. 3. Japanese Encephalitis is transmitted by Aedes aegypti mosquitoes. Which of the statements given above are correct?
11PM Modi launched the nationwide HPV vaccination drive for girls in February 2026 from which city in Rajasthan?
12Consider the following statements: 1. In 2021, IDSP shifted to paperless, case-based, near-real-time reporting through IHIP. 2. The West Bengal Nipah cluster involved two healthcare workers at a private hospital in Barasat, North 24 Parganas. 3. The Nipah confirmation was done by the National Institute of Virology, Pune. 4. WHO assessed the overall Nipah risk as high. Which of the statements given above are correct?
13India's first indigenous COVID-19 testing kit was developed by:
14PathGennie, highlighted by the Ministry of Science and Technology as a key 2025 achievement, is a computational framework developed for:
15Consider the following about COVID-19 vaccines developed/manufactured in India: 1. Covaxin is an mRNA vaccine. 2. Covishield was developed by Oxford-AstraZeneca and manufactured by SII. 3. iNCOVACC is India's intranasal COVID vaccine. Which statements are correct?